Endocrinology

Clinical Trials Diabetes Biomedical Research Funding Patient Outcomes Weight Management Chronic Diseases Clinical Studies Pharmacology Autoimmune Diseases

3 ARTICLES

3w ago

Semaglutide Boosts Glycemic Control and Reduces Weight in Type 1 Diabetes Trial

Participants in the 26-week ADJUST-T1D trial experienced significant gains in target blood sugar range alongside substantial weight loss with weekly semaglutide.

9 ARTICLES

last mo.

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

4 ARTICLES

2mo ago

First Human Trial of Type 1 Diabetes Immunotherapy Underway in Australia

Endocrinology

Semaglutide Boosts Glycemic Control and Reduces Weight in Type 1 Diabetes Trial

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Brain Neurons Found to Drive Type 2 Diabetes, Independent of Obesity

Researchers Advance TYK2 Inhibitor Toward Type 1 Diabetes Clinical Trials

Study Advocates Demographic-Specific Guidelines for Thyroid Disease Diagnosis

First Human Trial of Type 1 Diabetes Immunotherapy Underway in Australia